Table 1. Clinical characteristics of the study population as a whole and by blood pressure control status.
| Whole group | Controlled HT | Uncontrolled HT | ||
| Variable | (n = 298) | (n = 67) | (n = 231) | p-value |
| Age, years | 64 ± 10 | 64 ± 10 | 64 ± 10 | |
| Gender, % | ||||
| Males | 30 | 27 | 31 | 0.548 |
| Females | 70 | 73 | 69 | |
| DHT, % | 0.179 | |||
| < 1 year | 15 | 16 | 14 | |
| 1–4 years | 29 | 39 | 26 | |
| 5–9 years | 23 | 19 | 24 | |
| ≥ 10 years | 33 | 26 | 35 | |
| FH-HT, % | 50 | 49 | 50 | 0.851 |
| FH-DM, % | 31 | 22 | 34 | 0.166 |
| BMI, kg/m2 | 26 ± 5 | 26 ± 5 | 25 ± 5 | 0.238 |
| WC, cm | 90 ± 11 | 90 ± 11 | 90 ± 11 | 0.953 |
| SBP, mmHg | 151 ± 24 | 122 ± 10 | 160 ± 20 | 0.001 |
| DBP, mmHg | 87 ± 14 | 75 ± 7 | 91 ± 13 | 0.001 |
| MBP, mmHg | 109 ± 16 | 91 ± 7 | 114 ± 13 | 0.001 |
| PP, mmHg | 64 ± 19 | 47 ± 9 | 69 ± 18 | 0.001 |
| Pulse rate, bpm | 76 ± 13 | 77 ± 12 | 77 ± 13 | 0.493 |
| AntiHT regimen, % | ||||
| 1 drug | 66 | 75 | 66 | 0.171 |
| ≥ 2 drugs | 34 | 25 | 34 | |
| Non-drug compliance, % | 42 | 42 | 42 | 0.050 |
Data are expressed as mean ± standard deviation (SD) or relative frequency (%). DHT, duration of hypertension; FH-HT, family history of hypertension; FH-DM, family history of diabetes mellitus; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; MBP, mean blood pressure; PP, pulse pressure; bpm, beats per minute; AntiHT, antihypertensive.